Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 24.97
-0.88 (-3.40%)
Aug 31, 2026, 3:04 PM CST
SHE:002317 Market Cap
SHE:002317 has a market cap or net worth of 21.97 billion as of August 31, 2026. Its market cap has increased by 22.04% in one year.
Market Cap
21.97B
Enterprise Value
20.99B
Revenue
2.22B
Ranking
n/a
PE Ratio
108.59
Stock Price
24.97
ChartMarket Cap Chart
Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 21.97B, an increase of 204.51%. That is a compound annual growth rate of 6.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 21.97B | 36.20% |
| Dec 31, 2025 | 16.13B | 56.94% |
| Dec 31, 2024 | 10.28B | -24.46% |
| Dec 29, 2023 | 13.61B | -37.64% |
| Dec 30, 2022 | 21.82B | 126.34% |
| Dec 31, 2021 | 9.64B | 8.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.19B |
| Apeloa Pharmaceutical Co.,Ltd | 24.01B |
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |
| Tasly Pharmaceutical Group | 22.24B |
| Jilin Aodong Pharmaceutical Group | 21.83B |